Aenova Invests in Extra Production Capacity at Carugate Site


CDMO will financially commit $10.6 million toward semi-solid and non-sterile liquid production.

Image Credit: Aenova

Image Credit: Aenova

Semi-solids for pharmaceuticals, medical devices, and cosmetics, as well as non-sterile liquids, continue to experience increasing demand. To meet these growing market needs, Aenova, a contract development and manufacturing organization (CDMO), is installing new equipment at its Carugate site in Italy. The investment of approximately $10.5 million will go toward the implementation of four projects: a new filling line for non-sterile liquids, a more efficient turbo-emulsifier, a more complex filling line for cosmetics, and a larger warehouse.

The new filling line for non-sterile liquids will increase capacity to more than 10 million units per year. The line also enables the filling of bottles with variable dosages from 10 ml to 350 ml, and different types of closures (screw or crimp of metal and plastic cap, spray, dropper). The new turbo-emulsifier means that the facility can now manufacture batch sizes ranging from 300 liters to 5,000 liters. The newly built warehouse next to the plant increases capacity by almost 3,000 pallet spaces, providing additional good manufacturing practice (GMP) storage to meet the growing demand.

"With the implementation of these four projects, we will effectively have a completely new plant with more modern and more efficient equipment by the end of 2023,” says Marco Falzolgher, managing director of the Aenova site in Carugate. " … Not only will we be able to better respond to market needs and customer requests, but we will also be able to expand our service offering to reliably provide products to patients and consumers around the world."

Related Videos
© 2024 MJH Life Sciences

All rights reserved.